Funkcinė medicina - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 24,349 | 24,438 | 27,065 | 26,203 | 41,905 | 53,330 | 59,130 | 63,340 |
| Profit before tax | 1,725 | -1,888 | 3,694 | -3,851 | 2,747 | 780 | 3,104 | 2,030 |
| Net profit | 1,699 | -1,888 | 3,631 | -3,851 | 2,747 | 780 | 2,943 | 1,903 |
| Equity | 2,715 | 828 | 4,458 | 607 | 3,354 | 4,134 | 7,077 | 8,980 |
| Liabilities | 226 | 60 | 249 | 586 | 1,746 | 1,347 | 1,788 | 1,647 |
| Non-current assets | 846 | 510 | 208 | 4 | 4 | 470 | 1,346 | 3,778 |
| Current assets | 2,073 | 367 | 4,499 | 1,152 | 5,096 | 4,991 | 7,506 | 6,849 |
| Total assets | 2,919 | 877 | 4,707 | 1,156 | 5,100 | 5,461 | 8,852 | 10,627 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 5,159 | 5,035 | 4,409 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +244.9% | +0.4% | +10.7% | -3.2% | +59.9% | +27.3% | +10.9% | +7.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 58.2% | -215.3% | 77.1% | -333.1% | 53.9% | 14.3% | 33.2% | 17.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 62.6% | -228.0% | 81.4% | -634.4% | 81.9% | 18.9% | 41.6% | 21.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.0% | -7.7% | 13.4% | -14.7% | 6.6% | 1.5% | 5.0% | 3.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.1% | -7.7% | 13.6% | -14.7% | 6.6% | 1.5% | 5.2% | 3.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 1.0 | 0.5 | 0.3 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 8,116 | 8,146 | 9,022 | 11,646 | 20,953 | 26,665 | 29,565 | 27,146 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Funkcinė medicina - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-10-23 | 2025-10-29 | 0.44 |
| 2025-08-31 | 2025-09-01 | 96.51 |
| 2025-08-19 | 2025-08-29 | 96.51 |
| 2025-07-28 | 2025-08-04 | 72.47 |
| 2025-07-26 | 2025-07-27 | 72.03 |
| 2025-07-24 | 2025-07-25 | 72.47 |
| 2025-07-16 | 2025-07-23 | 72.03 |
| 2025-06-17 | 2025-07-02 | 47.99 |
| 2025-05-16 | 2025-06-01 | 23.95 |
| 2025-04-30 | 2025-04-30 | 24.03 |
| 2025-04-28 | 2025-04-29 | 24.14 |
| 2025-04-26 | 2025-04-27 | 24.03 |
| 2025-04-24 | 2025-04-25 | 24.14 |
| 2025-04-16 | 2025-04-23 | 24.03 |
| 2025-03-25 | 2025-03-25 | 4.03 |
| 2025-03-18 | 2025-03-24 | 4.04 |
| 2025-03-04 | 2025-03-06 | 19.68 |
| 2025-02-18 | 2025-03-03 | 19.67 |
| 2025-02-10 | 2025-02-10 | 0.01 |
| 2025-01-22 | 2025-02-02 | 0.01 |
| 2024-12-22 | 2024-12-31 | 3.41 |
| 2024-12-17 | 2024-12-20 | 3.41 |
| 2024-07-24 | 2024-08-15 | 1.11 |
| 2024-06-18 | 2024-07-02 | 0.04 |
| 2024-05-16 | 2024-05-20 | 731.74 |
| 2024-02-19 | 2024-02-28 | 0.15 |
| 2024-01-16 | 2024-01-30 | 0.15 |
| 2023-01-17 | 2023-01-22 | 0.22 |
| 2022-12-16 | 2022-12-29 | 0.22 |
Funkcinė medicina - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-19 | 2025-08-12 | 0.08 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Funkcine medicina, UAB (code 302534543) is a Private Limited Liability Company engaged in other human health activities n.e.c. In the latest financial year, 2025, the company generated revenue of €63.3K and net profit of €1.9K, resulting in a profit margin of 3.0%. Revenue increased by 7.1% year on year in 2025 and by 18.8% over two years, showing steady top-line growth. Profitability was stronger in 2024, when net profit reached €2.9K and the margin was 5.0%, before easing in 2025. Over the three-year period, net profit moved from €780 in 2023 to €2.9K in 2024 and €1.9K in 2025. At year-end 2025, total assets were €10.6K, equity €9.0K and liabilities €1.6K, indicating a solid equity position. The equity ratio stood at 84.5%, debt-to-equity at 0.18, and asset turnover at 5.96x. Revenue per employee was €31.7K, with profit per employee of €952.